Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma

作者：Schwarz Lilian; Katz Matthew Harold G^*

来源：Hematology-Oncology Clinics of North America, 2015, 29(4): 727-+.

DOI：10.1016/j.hoc.2015.04.004

• Borderline resectable
• Pancreatic cancer
• Pancreatoduodenectomy
• Neoadjuvant therapy
• Chemotherapy
• Chemoradiation

Borderline resectable pancreatic cancer represents a subcategory of advanced cancer that is typically defined by limited involvement of the major mesenteric vasculature. Such involvement is associated with a high likelihood of microscopically incomplete resection if surgery is used as the primary therapeutic modality. Increasing data support the role of neo-adjuvant therapy as part of multimodality management but there is no uniformly accepted standard of care. This review discusses, based on recent literature and the experience of the Pancreatic Tumor Study Group at The University of Texas MD Anderson Cancer Center, the classification, definition, diagnosis, and management of borderline resectable pancreatic cancer.

• 出版日期2015-8